title: The MHP36 line of murine neural stem cells expresses functional CXCR1 chemokine receptors that initiate chemotaxis in vitro.
abstract: Chemokines help to establish cerebral inflammation after ischemia, which comprises a major component of secondary brain injury. The CXCR4 chemokine receptor system induces neural stem cell migration, and hence has been implicated in brain repair. We show that CXCR1 and interleukin-8 also stimulate chemotaxis in murine neural stem cells from the MHP36 cell line. The presence of CXCR1 was confirmed by reverse transcriptase PCR and immunohistochemistry. Interleukin-8 evoked intracellular calcium currents, upregulated doublecortin (a protein expressed by migrating neuroblasts), and elicited positive chemotaxis in vitro. Therefore, effectors of the early innate immune response may also influence brain repair mechanisms.
authors.affiliation: Division of Anaesthesia, University of Cambridge, Box 93, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, United Kingdom.
authors.forename: John Samuel
authors.initials: JS
authors.lastname: Beech
authors.forename: Daniel Wren
authors.initials: DW
authors.lastname: Wheeler
authors.forename: Jill
authors.initials: J
authors.lastname: Reckless
authors.forename: Andrew James
authors.initials: AJ
authors.lastname: Grant
authors.forename: Jack
authors.initials: J
authors.lastname: Price
authors.forename: Pietro
authors.initials: P
authors.lastname: Mastroeni
authors.forename: David John
authors.initials: DJ
authors.lastname: Grainger
authors.forename: David Krishna
authors.initials: DK
authors.lastname: Menon
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002460:Cell Line; D002465:Cell Movement / Q000187:drug effects / Q000502:physiology; D002633:Chemotaxis / Q000187:drug effects / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D000089622:Doublecortin Domain Proteins; D004347:Drug Interactions; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005434:Flow Cytometry / Q000379:methods; D015870:Gene Expression / Q000187:drug effects / Q000502:physiology*; D007150:Immunohistochemistry / Q000379:methods; D066298:In Vitro Techniques; D016209:Interleukin-8 / Q000494:pharmacology; D051379:Mice; D008869:Microtubule-Associated Proteins / Q000378:metabolism; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D009479:Neuropeptides / Q000378:metabolism; D010456:Peptides, Cyclic / Q000494:pharmacology; D012333:RNA, Messenger / Q000096:biosynthesis; D023062:Receptors, Interleukin-8A / Q000235:genetics / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D013234:Stem Cells / Q000187:drug effects / Q000378:metabolism*
chemical_list: D000089622:Doublecortin Domain Proteins; D004791:Enzyme Inhibitors; D016209:Interleukin-8; D008869:Microtubule-Associated Proteins; D009479:Neuropeptides; D010456:Peptides, Cyclic; D012333:RNA, Messenger; D023062:Receptors, Interleukin-8A; C411952:cyclo(cysteinyl-glutaminyl-isoleucyl-tryptophyl-lysyl-glutaminyl-lysyl-prolyl-aspartyl-leucyl-cysteinyl-amide); D002118:Calcium